Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 70961501000001111 | Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 70961601000001110 | Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Is a | Citric acid + Potassium citrate + Sodium citrate | true | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Continuous dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solution.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Is a | Citric acid + Potassium citrate + Sodium citrate | false | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has dispensed dose form | Conventional release oral solution | true | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has specific active ingredient | Sodium citrate dihydrate | false | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has specific active ingredient | Citric acid monohydrate | false | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has specific active ingredient | Potassium citrate monohydrate | false | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has active ingredient | Citric acid | false | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has active ingredient | Potassium citrate | false | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has active ingredient | Sodium citrate | false | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has manufactured dose form | Conventional release oral solution | false | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has specific active ingredient | Sodium citrate dihydrate | true | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has specific active ingredient | Citric acid monohydrate | true | Inferred relationship | Existential restriction modifier | ||
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Has specific active ingredient | Potassium citrate monohydrate | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tricitrates oral solution (Drug Tariff Special Order) | Is a | True | Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Inferred relationship | Existential restriction modifier | |
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution 500 ml | Has VMP | True | Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Inferred relationship | Existential restriction modifier | |
| Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution 1 ml | Has VMP | True | Citric acid monohydrate 334mg/5ml / Potassium citrate monohydrate 550mg/5ml / Sodium citrate dihydrate 500mg/5ml oral solution | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR